Horizon Discovery Horizon Discovery Licenses Gene-Edited Cell Line to Sanyou Biopharmaceuticals Sanyou will use the cell line in the development of preclinical antibody drug projects and to support its customers' human biotherapeutic products. PerkinElmer to Buy Horizon Discovery for $383M The deal allows PerkinElmer to expand its portfolio of automated life sciences discovery and applied genomics products to include gene editing and gene modulation tools. Horizon Discovery H1 Revenues Fall 14 Percent The gene editing and gene modulation technologies firm attributed the decline to the impact of the SARS-CoV-2 pandemic on its research reagents business. New Products Posted to GenomeWeb: Illumina, NIST, Horizon Discovery, More Horizon Discovery Revenues Up 8 Percent in 2019 The Cambridge, UK-based firm saw double-digit growth in its screening business and declines in its bioproduction and diagnostics businesses. Feb 21, 2020 Horizon Aims to Build Unique Portfolio of Gene Editing Tools While Avoiding IP Woes Premium Feb 4, 2020 Horizon Discovery Preliminary FY2019 Revenues Up 7 Percent Jan 30, 2020 Mammoth Biosciences Enters New Phase of Business Strategy With Horizon Deal, $45M Fundraise Premium Jan 16, 2020 JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More Jan 14, 2020 Rutgers Licenses Base Editing Tech to Horizon Discovery Jan 13, 2020 Horizon Discovery, Mammoth Biosciences Sign Second CRISPR Tools Development Agreement Dec 13, 2019 Horizon Discovery, Mammoth Biosciences Team Up to Develop CRISPR Tools Dec 13, 2019 New Products Posted to GenomeWeb: Horizon Discovery, Fluxion Biosciences, Caris Life Sciences, More Dec 3, 2019 Human Protein Atlas to Use Horizon Discovery Cell Models Sep 16, 2019 Horizon Discovery Revenues Up 14 Percent in H1 Mar 25, 2019 Horizon Discovery, St. George's University Hospital, EMQN to Develop NIPT Reference Material Jan 28, 2019 Horizon Discovery, Rutgers Collaborate to Commercialize CRISPR Base Editing Technology Sep 17, 2018 Horizon Discovery Revenues Double in H1 Aug 28, 2018 Horizon Discovery Begins Leveraging Vast Portfolio of Genome Editing Technology Premium Jul 18, 2018 Inscripta Confirms CRISPR-MAD7 Editing Activity in Mammalian Cells, Releases New MAD2 Enzyme Premium May 11, 2018 People in the News: Terry Pizzie, Stephanie Bywater, Michael Stocum May 9, 2018 Abcam Drops Takeover Bid for Horizon Discovery May 8, 2018 Horizon Discovery Preliminary 2017 Revenues Up 52 Percent May 2, 2018 Horizon Discovery Rejects £270M Takeover Offer From Abcam Dec 18, 2017 Roche, Horizon Ink IHC Reference Standard Development Deal Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.